Search results - 44 results
Herpes zoster in Belgium: a new solution to an old problem
Keywords: Belgium epidemiology Herpes zoster recombinant zoster vaccine Vaccination Abstract: Herpes zoster (HZ) is caused by reactivation of the varicella-zoster virus. The life-time risk of developing HZ is ...
Characterisation and Hazard identification of substandard and Falsified Antimicrobial Drugs. The CantiBio project 2016-2020
the amount of drug released is under the limit at the time point described by the USP. In addition to that, low equivalences of dissolution profiles between SF antimicrobials and genuine products were ...
NATIONAL SURVEILLANCE OF SARS-COV-2 IN WASTEWATER- How does WBE contribute to the global epidemiologic assessment in Belgium? (September 2020 – 2024)
tool, especially at the time where the testing capacity was high. Also, a preceding character was evidenced in several areas and is discussed in a dedicated section of the present report. Finally, results ...
Recovering radiotherapy services in England: Our plan for action
visibility in the public debate as chemotherapy and other cancer treatments. This briefing explores the main drivers of lengthening waiting times for radiotherapy and what action we need at a national and ...
A One-Health approach to monitoring antimicrobial consumption in Belgium 2012-2021
were performed to assess the correlation between AMC and time. Results Significant reductions in total AMC (mg/kg estimated biomass) were observed over time in both humans and animals. Notably, in ...
Prevalence of Healthcare-Associated Infections in Belgian Acute Care Hospitals in 2022: Results of ECDC Point Prevalence Survey
level. All patients present in the surveyed wards at 8 a.m. on the PPS day and not discharged at that time, were included. Modifications from the 2017 protocol included the incorporation of infection ...
Closing the gap: Oxford Nanopore Technologies R10 sequencing allows comparable results to Illumina sequencing for SNP-based outbreak investigation of bacterial pathogens.
evaluated not only separately but also by integrating samples sequenced by different technologies/chemistries into the same phylogenomic analysis. Additionally, the minimum sequencing time required to obtain ...
Closing the gap: Oxford Nanopore Technologies R10 sequencing allows comparable results to Illumina sequencing for SNP-based outbreak investigation of bacterial pathogens.
evaluated not only separately but also by integrating samples sequenced by different technologies/chemistries into the same phylogenomic analysis. Additionally, the minimum sequencing time required to obtain ...
Closing the gap: Oxford Nanopore Technologies R10 sequencing allows comparable results to Illumina sequencing for SNP-based outbreak investigation of bacterial pathogens.
evaluated not only separately but also by integrating samples sequenced by different technologies/chemistries into the same phylogenomic analysis. Additionally, the minimum sequencing time required to obtain ...
Closing the gap: Oxford Nanopore Technologies R10 sequencing allows comparable results to Illumina sequencing for SNP-based outbreak investigation of bacterial pathogens.
phylogenomic analysis. Additionally, the minimum sequencing time required to obtain accurate phylogenetic results using nanopore sequencing was evaluated. PACU allowed accurate identification of outbreak ...